Back to VYNE

CITADEL ADVISORS LLC → VYNE

CITADEL ADVISORS LLC VYNE Position History

VYNE Therapeutics Inc • Healthcare

Quarters held
15
Latest value
$305K
Q2 2026
Peak value
$4M
First seen
Q4 2023

Dollar value over time

Show data table
PeriodPosition value
Q4 2023$2.8M
Q1 2024$3.6M
Q2 2024$2.3M
Q2 2024$59K
Q3 2024$2.2M
Q3 2024$12K
Q4 2024$4M
Q4 2024$165K
Q1 2025$1.6M
Q1 2025$95K
Q2 2025$1.7M
Q4 2025$18K
Q1 2026$307K
Q2 2026$305K
Q2 2026$305K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$305K468.5K——
Q2 2026$305K468.5K——
Q1 2026$307K514.4K——
Q4 2025$18K30.5K——
Q2 2025$1.7M1.04M——
Q1 2025$95K60.3K——
Q1 2025$1.6M1.04M——
Q4 2024$165K49.4K——
Q4 2024$4M1.18M——
Q3 2024$12K6.3K——
Q3 2024$2.2M1.18M——
Q2 2024$59K30.0K——
Q2 2024$2.3M1.18M——
Q1 2024$3.6M1.18M——
Q4 2023$2.8M1.18M——

Other funds holding VYNE

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B